WestEnd Advisors LLC cut its holdings in UnitedHealth Group (NYSE:UNH) by 17.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,793 shares of the healthcare conglomerate’s stock after selling 44,993 shares during the quarter. UnitedHealth Group makes up approximately 4.4% of WestEnd Advisors LLC’s portfolio, making the stock its 7th largest holding. WestEnd Advisors LLC’s holdings in UnitedHealth Group were worth $47,794,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in UNH. Capital International Investors grew its position in shares of UnitedHealth Group by 399.3% in the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares during the last quarter. Jennison Associates LLC boosted its position in UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares during the last quarter. Janus Henderson Group PLC boosted its position in UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares during the last quarter. Vanguard Group Inc. boosted its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the last quarter. Finally, Parametric Portfolio Associates LLC boosted its position in UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares during the last quarter. Institutional investors and hedge funds own 86.79% of the company’s stock.
A number of brokerages recently issued reports on UNH. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 target price on the stock in a research report on Tuesday, April 3rd. Cantor Fitzgerald restated a “buy” rating and set a $280.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 8th. Citigroup raised their target price on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Oppenheimer raised their target price on shares of UnitedHealth Group from $260.00 to $240.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Finally, Deutsche Bank raised their target price on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Two investment analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $244.06.
In other news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction on Monday, March 19th. The shares were sold at an average price of $224.36, for a total value of $2,243,600.00. Following the transaction, the director now owns 1,771,257 shares of the company’s stock, valued at approximately $397,399,220.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Steven H. Nelson sold 14,233 shares of the firm’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $230.22, for a total transaction of $3,276,721.26. Following the completion of the transaction, the chief executive officer now directly owns 18,219 shares in the company, valued at approximately $4,194,378.18. The disclosure for this sale can be found here. In the last three months, insiders sold 77,015 shares of company stock worth $17,879,199. Insiders own 0.89% of the company’s stock.
Shares of UNH stock traded down $5.11 during mid-day trading on Friday, reaching $223.96. The company’s stock had a trading volume of 3,231,724 shares, compared to its average volume of 4,007,180. UnitedHealth Group has a 12-month low of $164.60 and a 12-month high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. The company has a market cap of $216,717.81, a PE ratio of 22.24, a P/E/G ratio of 1.31 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter last year, the firm posted $2.11 EPS. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group will post 12.51 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 29.79%.
WARNING: “WestEnd Advisors LLC Sells 44,993 Shares of UnitedHealth Group (UNH)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/08/unitedhealth-group-inc-unh-is-westend-advisors-llcs-7th-largest-position.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.